Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Tongue Hyperpigmentation Resulting From Peginterferon Alfa and Ribavirin Combination Therapy
The Journal of the American Dental Association , 11/05/09
de Moraes PC et al. – Dentists should be aware that hyperpigmentation of the tongue can result from peginterferon alfa and ribavirin combination therapy. A biopsy should be performed if no firm diagnosis can be obtained from clinical findings and the patient’s medical history.
Related Articles
Tongue plaque with offensive odor
The Clinical Advisor, 11/13/09
Relevance Score: 46%
Atypical lipomatous tumors of the tongue: report of six cases
Virchows Archiv, 10/14/09
Relevance Score: 44%
Treatment of periocular hyperpigmentation due to lead of kohl (surma) by penicillamine: A single group non-randomized clinical trial
Indian Journal of Dermatology, 11/13/09
Relevance Score: 43%
Comparison between tongue volume from magnetic resonance images and tongue area from profile cephalograms
European Journal of Orthodontics, 11/10/09
Relevance Score: 43%
Dismissing links between HPV and aggressive tongue cancer in young patients
Annals of Oncology, 10/20/09
Relevance Score: 43%
Today in Hepatitis...keeping you current
Receive free subspecialty "5-minute updates" via email
Different models of HBeAg seroconversion predicated by on-treatment ALT and HBV DNA profiles
Journal of Viral Hepatitis, 11/25/09
Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy
Journal of Viral Hepatitis, 11/25/09
Mutation frequency of NS5A in patients vertically infected with HCV genotype 1 predicts sustained virological response to peginterferon alfa-2b and ribavirin combination therapy
Journal of Viral Hepatitis, 11/25/09
Article Search
Sponsor


See Latest Articles


